Therios 750 mg Palatable Tablets for Dogs
Država: Madžarska
Jezik: angleščina
Source: HMA (Heads of Medicines Agencies)
Lastnosti izdelka
(SPC)
10-04-2013
Nekateri dokumenti za ta izdelek trenutno niso na voljo, pošljete lahko zahtevo v našo stranko in obvestili vas bomo takoj, ko jih bomo lahko pridobili.
Pošlji zahtevo.
Pošlji zahtevo.
Aktivna sestavina:
cefalexin monohydrate 750 mg
Dostopno od:
Laboratories Sogeval
Koda artikla:
QJ01DB01
Farmacevtska oblika:
Tablet
Terapevtska skupina:
Cefalexin
Terapevtsko območje:
Dogs
Datum dovoljenje:
2011-01-04
Lastnosti izdelka
Revised: May 2012
AN: 00601/2011
Page - 1 - of 6
SUMMARY OF PRODUCT CHACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
UK, AT, IE, PL, CZ, BE,
HU, GK, LUX, NL, PT
Therios 750 mg palatable tablets for dogs
IT, ES, FI
Therios 750 mg flavoured tablets for dogs
DE
Therios 750 mg aromatisierte Tabletten für Hunde
NO
Therios 750 mg, tyggetablett til hund.
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
ACTIVE SUBSTANCE:
Each tablet contains:
Cefalexin (as cefalexin monohydrate)...........................750 mg
For a full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Tablet
Round scored beige palatable tablet
The tablet can be divided into equal halves and quarters
4.
CLINICAL PARTICULARS
4.1 TARGET SPECIES
Dogs
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the treatment of bacterial skin infections in dogs (including deep and
superficial pyoderma) caused by organisms sensitive to cefalexin.
For the treatment of urinary tract infections in dogs (including nephritis and cystitis)
caused by organisms sensitive to cefalexin.
4.3 CONTRAINDICATIONS
Do not use in animals which are known to be hypersensitive to penicillins.
Do not use in case of severe renal failure
Do not use in rabbits, guinea pigs, hamsters and gerbils.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
Revised: May 2012
AN: 00601/2011
Page - 2 - of 6
4.5 SPECIAL PRECAUTIONS FOR USE
i.
Special precautions for use in animals
As with other antibiotics which are excreted mainly by the kidneys, systemic
accumulation may occur when renal function is impaired. In case of known
renal insufficiency the dose should be
Preberite celoten dokument
